Anti-Human CD71 (Transferrin Receptor) Functional Grade Purified

Also known as: TFRC, TFR, TFR1, TRFR

Clone: OKT9 (OKT-9)

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# 16-0719

Cat. No. Size
16-0719-81 50 ug
16-0719-85 500 ug

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Anti-Human CD71 (Transferrin Receptor) Functional Grade Purified.

Description

Description: The OKT9 monoclonal antibody reacts with human CD71, a 170-180 kDa type II transmembrane protein. CD71, the transferrin receptor, exists as a homodimer on the cell surface and is essential for cellular growth. CD71 is expressed by immature proliferating cells and at low levels on resting mature lymphocytes. Antigen or mitogen stimulation of T and B cells upregulates the expression of CD71.

Details
Host Mouse
Isotype IgG1
Reactivity Human
Conjugate Functional Grade Purified
Reported Applications Flow Cytometric Analysis
Documentation

For complete product information, please download the TDS or IFU document.

TDS Link Download TDS
Additional Formats
Cat. No. Name Excite Emit Application Reg.
17-0719 Anti-Human CD71 (Transferrin Receptor) APC 633 nm 660 nm FC RUO
11-0719 Anti-Human CD71 (Transferrin Receptor) FITC 488 nm 518 nm FC RUO
13-0719 Anti-Human CD71 (Transferrin Receptor) Biotin FC RUO
12-0719 Anti-Human CD71 (Transferrin Receptor) PE 488 nm 575 nm FC RUO
14-0719 Anti-Human CD71 (Transferrin Receptor) Purified FC RUO
References

References:
Sutherland R, Delia D, Schneider C, Newman R, Kemshead J, Greaves M. 1981. Ubiquitous cell-surface glycoprotein on tumor cells is proliferation-associated receptor for transferrin. Proc Natl Acad Sci U S A. 78(7): 4515–4519.

Salcedo TW, Fleit HB. 1991. Plasma membrane and intracellular pools of transferrin receptors decline during in vitro cultivation of U937 cells. Cell Prolif. 24(4):383-401.

Wenning LA, Murphy RM. 1999. Coupled cellular trafficking and diffusional limitations in delivery of immunotoxins to multicell tumor spheroids. Biotechnol Bioeng. 62(5):562-75.